The global Virtual Drug Discovery Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Virtual Drug Discovery Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Virtual Drug Discovery Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Virtual Drug Discovery Service in Biotech and Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Virtual Drug Discovery Service include Profacgen, CD ComputaBio, Creative Biolabs, BOC Sciences, Jubilant Biosys, MedChemExpress (MCE), HitGen, TargetMol Chemicals and WuXi AppTec, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Virtual Drug Discovery Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virtual Drug Discovery Service.
The Virtual Drug Discovery Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Virtual Drug Discovery Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Virtual Drug Discovery Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Profacgen
CD ComputaBio
Creative Biolabs
BOC Sciences
Jubilant Biosys
MedChemExpress (MCE)
HitGen
TargetMol Chemicals
WuXi AppTec
LeadBuilder - Domainex
CSNpharm
ChemNavigator
CKTTDB
Molinspiration
Molsoft
Southwest Research Institute
Segment by Type
Structure-based Virtual Screening (SBVS)
Ligand-based Virtual Screening (LBVS)
Others
Segment by Application
Biotech and Pharmaceutical Companies
Academic Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Virtual Drug Discovery Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Drug Discovery Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Structure-based Virtual Screening (SBVS)
1.2.3 Ligand-based Virtual Screening (LBVS)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Virtual Drug Discovery Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biotech and Pharmaceutical Companies
1.3.3 Academic Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Virtual Drug Discovery Service Market Perspective (2018-2029)
2.2 Virtual Drug Discovery Service Growth Trends by Region
2.2.1 Global Virtual Drug Discovery Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Virtual Drug Discovery Service Historic Market Size by Region (2018-2023)
2.2.3 Virtual Drug Discovery Service Forecasted Market Size by Region (2024-2029)
2.3 Virtual Drug Discovery Service Market Dynamics
2.3.1 Virtual Drug Discovery Service Industry Trends
2.3.2 Virtual Drug Discovery Service Market Drivers
2.3.3 Virtual Drug Discovery Service Market Challenges
2.3.4 Virtual Drug Discovery Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virtual Drug Discovery Service Players by Revenue
3.1.1 Global Top Virtual Drug Discovery Service Players by Revenue (2018-2023)
3.1.2 Global Virtual Drug Discovery Service Revenue Market Share by Players (2018-2023)
3.2 Global Virtual Drug Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Virtual Drug Discovery Service Revenue
3.4 Global Virtual Drug Discovery Service Market Concentration Ratio
3.4.1 Global Virtual Drug Discovery Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Drug Discovery Service Revenue in 2022
3.5 Virtual Drug Discovery Service Key Players Head office and Area Served
3.6 Key Players Virtual Drug Discovery Service Product Solution and Service
3.7 Date of Enter into Virtual Drug Discovery Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Virtual Drug Discovery Service Breakdown Data by Type
4.1 Global Virtual Drug Discovery Service Historic Market Size by Type (2018-2023)
4.2 Global Virtual Drug Discovery Service Forecasted Market Size by Type (2024-2029)
5 Virtual Drug Discovery Service Breakdown Data by Application
5.1 Global Virtual Drug Discovery Service Historic Market Size by Application (2018-2023)
5.2 Global Virtual Drug Discovery Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Virtual Drug Discovery Service Market Size (2018-2029)
6.2 North America Virtual Drug Discovery Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Virtual Drug Discovery Service Market Size by Country (2018-2023)
6.4 North America Virtual Drug Discovery Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Virtual Drug Discovery Service Market Size (2018-2029)
7.2 Europe Virtual Drug Discovery Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Virtual Drug Discovery Service Market Size by Country (2018-2023)
7.4 Europe Virtual Drug Discovery Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Virtual Drug Discovery Service Market Size (2018-2029)
8.2 Asia-Pacific Virtual Drug Discovery Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Virtual Drug Discovery Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Virtual Drug Discovery Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Virtual Drug Discovery Service Market Size (2018-2029)
9.2 Latin America Virtual Drug Discovery Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Virtual Drug Discovery Service Market Size by Country (2018-2023)
9.4 Latin America Virtual Drug Discovery Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Virtual Drug Discovery Service Market Size (2018-2029)
10.2 Middle East & Africa Virtual Drug Discovery Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Virtual Drug Discovery Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Virtual Drug Discovery Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Profacgen
11.1.1 Profacgen Company Detail
11.1.2 Profacgen Business Overview
11.1.3 Profacgen Virtual Drug Discovery Service Introduction
11.1.4 Profacgen Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.1.5 Profacgen Recent Development
11.2 CD ComputaBio
11.2.1 CD ComputaBio Company Detail
11.2.2 CD ComputaBio Business Overview
11.2.3 CD ComputaBio Virtual Drug Discovery Service Introduction
11.2.4 CD ComputaBio Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.2.5 CD ComputaBio Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Detail
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Virtual Drug Discovery Service Introduction
11.3.4 Creative Biolabs Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.3.5 Creative Biolabs Recent Development
11.4 BOC Sciences
11.4.1 BOC Sciences Company Detail
11.4.2 BOC Sciences Business Overview
11.4.3 BOC Sciences Virtual Drug Discovery Service Introduction
11.4.4 BOC Sciences Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.4.5 BOC Sciences Recent Development
11.5 Jubilant Biosys
11.5.1 Jubilant Biosys Company Detail
11.5.2 Jubilant Biosys Business Overview
11.5.3 Jubilant Biosys Virtual Drug Discovery Service Introduction
11.5.4 Jubilant Biosys Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.5.5 Jubilant Biosys Recent Development
11.6 MedChemExpress (MCE)
11.6.1 MedChemExpress (MCE) Company Detail
11.6.2 MedChemExpress (MCE) Business Overview
11.6.3 MedChemExpress (MCE) Virtual Drug Discovery Service Introduction
11.6.4 MedChemExpress (MCE) Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.6.5 MedChemExpress (MCE) Recent Development
11.7 HitGen
11.7.1 HitGen Company Detail
11.7.2 HitGen Business Overview
11.7.3 HitGen Virtual Drug Discovery Service Introduction
11.7.4 HitGen Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.7.5 HitGen Recent Development
11.8 TargetMol Chemicals
11.8.1 TargetMol Chemicals Company Detail
11.8.2 TargetMol Chemicals Business Overview
11.8.3 TargetMol Chemicals Virtual Drug Discovery Service Introduction
11.8.4 TargetMol Chemicals Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.8.5 TargetMol Chemicals Recent Development
11.9 WuXi AppTec
11.9.1 WuXi AppTec Company Detail
11.9.2 WuXi AppTec Business Overview
11.9.3 WuXi AppTec Virtual Drug Discovery Service Introduction
11.9.4 WuXi AppTec Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.9.5 WuXi AppTec Recent Development
11.10 LeadBuilder - Domainex
11.10.1 LeadBuilder - Domainex Company Detail
11.10.2 LeadBuilder - Domainex Business Overview
11.10.3 LeadBuilder - Domainex Virtual Drug Discovery Service Introduction
11.10.4 LeadBuilder - Domainex Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.10.5 LeadBuilder - Domainex Recent Development
11.11 CSNpharm
11.11.1 CSNpharm Company Detail
11.11.2 CSNpharm Business Overview
11.11.3 CSNpharm Virtual Drug Discovery Service Introduction
11.11.4 CSNpharm Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.11.5 CSNpharm Recent Development
11.12 ChemNavigator
11.12.1 ChemNavigator Company Detail
11.12.2 ChemNavigator Business Overview
11.12.3 ChemNavigator Virtual Drug Discovery Service Introduction
11.12.4 ChemNavigator Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.12.5 ChemNavigator Recent Development
11.13 CKTTDB
11.13.1 CKTTDB Company Detail
11.13.2 CKTTDB Business Overview
11.13.3 CKTTDB Virtual Drug Discovery Service Introduction
11.13.4 CKTTDB Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.13.5 CKTTDB Recent Development
11.14 Molinspiration
11.14.1 Molinspiration Company Detail
11.14.2 Molinspiration Business Overview
11.14.3 Molinspiration Virtual Drug Discovery Service Introduction
11.14.4 Molinspiration Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.14.5 Molinspiration Recent Development
11.15 Molsoft
11.15.1 Molsoft Company Detail
11.15.2 Molsoft Business Overview
11.15.3 Molsoft Virtual Drug Discovery Service Introduction
11.15.4 Molsoft Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.15.5 Molsoft Recent Development
11.16 Southwest Research Institute
11.16.1 Southwest Research Institute Company Detail
11.16.2 Southwest Research Institute Business Overview
11.16.3 Southwest Research Institute Virtual Drug Discovery Service Introduction
11.16.4 Southwest Research Institute Revenue in Virtual Drug Discovery Service Business (2018-2023)
11.16.5 Southwest Research Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Profacgen
CD ComputaBio
Creative Biolabs
BOC Sciences
Jubilant Biosys
MedChemExpress (MCE)
HitGen
TargetMol Chemicals
WuXi AppTec
LeadBuilder - Domainex
CSNpharm
ChemNavigator
CKTTDB
Molinspiration
Molsoft
Southwest Research Institute
听
听
*If Applicable.
